Published in

American Association for Cancer Research, Cancer Epidemiology, Biomarkers & Prevention, 3(28), p. 616-619, 2019

DOI: 10.1158/1055-9965.epi-18-0909

Links

Tools

Export citation

Search in Google Scholar

Dietary Acrylamide Is Not Associated with Renal Cell Cancer Risk in the CPS-II Nutrition Cohort

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract Background: Acrylamide, an industrial chemical and probable human carcinogen, can be formed in primarily carbohydrate-containing foods during high-heat cooking or processing. Most epidemiologic studies show no associations of dietary acrylamide intake with most cancer outcomes, but limited prospective evidence suggests a positive association with renal cell carcinoma (RCC). Methods: In 1999, 102,154 men and women from the Cancer Prevention Study-II Nutrition Cohort completed a questionnaire on diet, lifestyle, and cancer risk factors and were followed through June 30, 2013. Cox proportional hazards regression was used to estimate the HR and 95% confidence interval (CI) for the association between estimated dietary acrylamide intake and risk of RCC. Results: After 1,137,441 person-years of follow-up, 412 cases of invasive RCC occurred. In multivariable-adjusted models, there was no association between acrylamide intake and risk of RCC (HR = 1.09; 95% CI, 0.82–1.43) for the highest versus lowest quartile of intake. Associations were not modified by sex or smoking history. Conclusions: We found no associations between dietary acrylamide exposure and risk of invasive RCC. Impact: The findings from this large, prospective analysis do not support a positive association between higher dietary acrylamide intake and RCC risk.